Skip to main content
. 2025 Mar 17;26(6):2686. doi: 10.3390/ijms26062686
BBN2 Antagonist bombesin peptide
CAR Chimeric Antigen Receptor
CT Computed tomography
DMEM Dulbecco’s Modified Eagle Medium
EC50 Half-maximum effective concentration
EDTA Ethylenediamine tetraacetic acid
EGFP Enhanced green fluorescent protein
ELISA Enzyme-linked immunosorbent assay
E:T Effector-to-target cell
FBS Fetal bovine serum
68Ga Gallium-68
GRP Gastrin-releasing peptide
GRPR Gastrin-releasing peptide receptor
HPLC High-performance liquid chromatography
IC50 Half-maximum inhibitory concentration
mAb Monoclonal antibody
MW Molecular weight
NOD-SCID Non-obese diabetic–severe combined immune-deficient
PBMCs Peripheral blood mononuclear cells
PBS Phosphate-buffered saline
PET Positron emission tomography
radio-TLC Radio-thin layer chromatography
scFv Single-chain variable fragment
SD Standard deviation
SDS-PAGE Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
SE-HPLC Size exclusion HPLC
SPAAC Strain-promoted azide–alkyne cycloaddition
SPE Solid-phase extraction
SPPS Solid-phase peptide synthesis
SUV Standard uptake value
TAA Tumor-associated antigen
TAC Time–activity curve
TCM Central memory T-cells
TEM Effector memory T-cells
TN/TSCM Naïve and stem cell-like memory T-cells
TTE Terminal effector T-cells
TM Target module
UniCAR Universal CAR